Careers

Look for job openings and other opportunities at Venture Center’s Career page

Seeking:

TechEx.in is looking for team members with the following backgrounds and interest areas:

Technology marketing
Technology transfer — deal structuring, agreements, valuations, negotiations
Spin-off and new venture creation
Intellectual property protection
Policies, institutional mechanisms and offices for innovation management
Industry- academia technology partnership mechanisms and contract management
Technology scouting and open innovation

Relevant backgrounds:

Science/ engineering + intellectual property
Science/ engineering + management (finance/ marketing/ strategic analysis)
Science/ engineering + law (business law, contracts, infringement)
Science/ engineering + venturing/startup experience
Documentation and record keeping support

Locations:

Onsite at Pune (majority of positions)
Offsite:
- Mumbai (1)
- Ahmedabad (1)
- Chennai/Bangalore/ Hyderabad (1)
- Delhi/ Chandigarh (1)

Jun 26, 2020

Creating Value from Bio‐resources: Understanding and Navigating the National Biodiversity Act This talk will focus on providing an overview of the regulatory regime under the Biological Diversity Act, 2002 and the Rules framed there under. Talk will look at the important provisions and approval requirements under the statute and most importantly understand the scope and […]

Jun 08, 2020

Understanding and Negotiating Non‐Disclosure Agreements (NDAs) & Material Transfer Agreements (MTAs) Non‐Disclosure Agreements are commonly signed between businesses entering into negotiations with other businesses which is a legally binding contract to establish a confidential relationship, so that parties can share sensitive information related to business plans with each other. Whereas MTA is a contract that […]

Jun 01, 2020

How important are patents and patent law in the COVID-19 pandemic? Drug repurposing has been gaining popularity as an approach to develop new medicines. In the present pandemic situation, an effort to find treatment for COVID-19, drug repurposing trials has gained focus. Since these drugs have already been deemed safe, development costs are reduced when […]